Ridgeback Capital - aVenture Asset Manager Research
Location
New York City, NY, US
Founded
2006
Ridgeback Capital is a New York City-based healthcare hedge fund specializing in life science investments. The firm focuses on investing in biotechnology, pharmaceutical, and medical technology companies across various stages of development, from early-stage startups to established public companies.
Notable portfolio companies include Freenome, Caribou Biosciences, and Butterfly Network. Ridgeback Capital's investment strategy emphasizes innovative healthcare solutions and breakthrough technologies. The firm's expertise in the life sciences sector allows it to provide valuable insights and support to its portfolio companies, helping them navigate the complex healthcare landscape and accelerate their growth.
Ridgeback Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages